| Application of static modeling in the prediction of in vivo drug–drug interactions between rivaroxaban and antiarrhythmic agents based on in vitro inhibition studies EJY Cheong, JJN Goh, Y Hong, G Venkatesan, Y Liu, GNC Chiu, ... Drug Metabolism and Disposition 45 (3), 260-268, 2017 | 44 | 2017 |
| Rivaroxaban with and without amiodarone in renal impairment EJY Cheong, JJN Goh, Y Hong, P Kojodjojo, ECY Chan Journal of the American College of Cardiology 71 (12), 1395-1397, 2018 | 36 | 2018 |
| Comparison of rivaroxaban concentrations between Asians and Caucasians and their correlation with PT/INR HO Ng Tsai, JJN Goh, JWX Aw, Y Lin, AYY Fong, LL Tiong, DSY Tan Journal of thrombosis and thrombolysis 46, 541-548, 2018 | 17 | 2018 |
| Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs JP Ernest, JJN Goh, N Strydom, Q Wang, RC van Wijk, N Zhang, ... European Respiratory Journal 62 (2), 2023 | 9 | 2023 |
| Structure-based virtual screening of CYP1A1 inhibitors: towards rapid tier-one assessment of potential developmental toxicants JJN Goh, J Behn, CS Chong, G Zhong, S Maurer-Stroh, H Fan, LH Loo Archives of Toxicology 95, 3031-3048, 2021 | 8 | 2021 |
| Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors TS Kyaw, C Zhang, M Sandy, K Trepka, S Zhang, LAR Hernandez, ... Iscience 27 (6), 2024 | 4 | 2024 |
| Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data JJN Goh, A Patel, B Ngara, RC van Wijk, N Strydom, Q Wang, N Van, ... iScience, 2025 | | 2025 |
| Prospectively predicting BPaMZ phase IIb/III trial outcomes using a translational mouse-to-human platform JJN Goh, Q Wang, N Zhang, N de Castro Suarez, AE Bustion, ... Antimicrobial Agents and Chemotherapy 68 (10), e00615-24, 2024 | | 2024 |
| Head and Neck Sarcoma Assessor (HaNSA) for treatment decisions using real-world data MYS See, JJN Goh, CE Low, CE Yau, WS Ong, RX Wong, NFM Noor, ... ESMO Real World Data and Digital Oncology 5, 100069, 2024 | | 2024 |
| Prospectively predicting BPaMZ Phase IIb outcomes using a translational preclinical mouse to human platform Q Wang, JJN Goh, N Zhang, E Nuermberger, R Savic bioRxiv, 2023.02. 16.528876, 2023 | | 2023 |
| Pharmacology in the Context of Pathogenic and Non Pathogenic Bacteria JJN Goh University of California, San Francisco, 2023 | | 2023 |
Pipin KojodjojoAsian Heart and Vascular Centre在 ahvc.com.sg 的电子邮件经过验证
